04/23/2026
Representation in clinical trials isn’t optional—it’s critical to data integrity.
Our studies consistently enroll a majority of participants from underrepresented populations—anchored in strong South Asian representation, with meaningful and growing inclusion of Black/African descent communities.
These populations face a disproportionate burden of cardiometabolic disease, yet remain historically underrepresented in research.
At Rasai Research, diversity isn’t incidental—it’s operational.
Through deep community engagement and a culturally aligned recruitment model, we deliver access to populations that are often difficult to reach—while maintaining speed, quality, and retention.
Better representation. Stronger data. More generalizable outcomes.